Docon Technologies Sells 9.9% Stake in Thyrocare

Docon Technologies Private Limited, a promoter and holding company of Thyrocare Technologies Limited, has sold 1,57,69,696 equity shares, representing approximately 9.9% of the total paid-up share capital. This sale reduces Docon's shareholding from 60.92% to 51.02%. The transaction was conducted off-market. Docon Technologies is a wholly owned subsidiary of API Holdings Limited. Following the sale, Docon continues to remain the promoter and holding company of Thyrocare.